342
Participants
Start Date
January 7, 2021
Primary Completion Date
September 27, 2024
Study Completion Date
September 27, 2024
Olaparib
Olaparib
Research Site, Bourg-en-Bresse
Research Site, Torino
Research Site, Genova
Research Site, Milan
Research Site, Milan
Research Site, Milan
Research Site, Besançon
Research Site, Bordeaux
Research Site, Aviano
Research Site, Langon
Research Site, Saint-Grégoire
Research Site, Tours
Research Site, Negrar
Research Site, Chambray-lès-Tours
Research Site, Grenoble
Research Site, Bologna
Research Site, Modena
Research Site, Parma
Research Site, Florence
Research Site, Nancy
Research Site, Roubaix
Research Site, Calais
Research Site, Lyon
Research Site, Pierre-Bénite
Research Site, Acquaviva delle Fonti
Research Site, Bari
Research Site, Epagny Metz-Tessy
Research Site, Paris
Research Site, Napoli
Research Site, Avignon
Research Site, Suresnes
Research Site, Saint-Cloud
Research Site, Villejuif
Research Site, Catania
Research Site, Cagliari
Research Site, Roma
Research Site, Roma
Research Site, Birmingham
Research Site, Cambridge
Research Site, Ediburgh
Research Site, Glasgow
Research Site, Guildford
Research Site, Leeds
Research Site, Liverpool
Research Site, Maidstone
Research Site, Manchester
Research Site, Newcastle
Research Site, Northampton
Research Site, Nottingham
Research Site, Portsmouth
Research Site, Swansea
Research Site, London
Research Site, London
Research Site, London
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY